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Interventions to prevent urinary catheter-associated infections in children and neonates: a 
systematic review  
 
Summary: 
Introduction 
Few data are available to inform strategies for the prevention of catheter-associated urinary tract 
infection (CAUTI) in children and neonates. Many recommendations are derived from studies in 
adults and cannot be applied to the paediatric population.  
Objective 
We aimed to identify all studies that measured the efficacy of an intervention for the prevention of 
CAUTI in children and neonates.  
Methods 
 We conducted a systematic review using the PRISMA guidelines. Eligible studies published 
between January 1st, 1995 and December 31st, 2017, were identified in PubMed, the Cochrane 
Database of Systematic Reviews, LILACS, SCIELO and DOAJ, if applying an intervention with 
the aim of CAUTI prevention in inpatient children, infants or neonates. The following study 
designs were included: controlled and non-controlled before-and-after studies, (controlled) 
interrupted time series analyses and randomized controlled trials. Quantitative or qualitative 
studies on interventions in both adults and children were eligible if data on children could be 
extracted. Reviews, case series, letters, notes, conference abstracts, and opinion articles were 
excluded.  
Results  
 Of 99 articles identified, six were included in the final analysis, following consensus from three 
independent investigators. Four studies used a multimodal strategy (utilizing at least four or more 
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different components at same time) as: aseptic rules during catheter insertion and removal; 
cleaning the urethral meatus with sterile water; use of a new silicone catheter per insertion with a 
closed sterile drainage system, using a sterile technique; daily evaluation of catheter requirement; 
placement of indwelling urinary catheters only for approved indications; reducing of urinary-
catheter-days and positioning of the patient and collection device to assist in urine drainage. One 
study tested peri-urethral cleaning intervention to reduce CAUTI. One study described the 
association of the presence of a physician safety champion with urinary catheter device utilization 
ratios (DUR). CAUTI reduction rates were reported in four studies; three achieved statistically 
significant decreases in CAUTI rates. Positive results were only achieved when a multimodal 
strategy was utilized using at least four or more components. This strategy could be adopted for 
paediatric healthcare institutions in order to reduce CAUTI rates in children and neonates.  
 
Conclusion 
 Evidence exists to support the use of a multimodal strategy for CAUTI reduction in hospitalised 
children and neonates.  
 
Key words: systematic review, catheter-associated urinary tract infection, children, intervention, 
prevention 
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Introduction: 
Catheter-associated urinary tract infection (CAUTI) is one of the most common, yet laregely 
preventable healthcare-associated infections (HAI) in hospitalized patients.1-5 A systematic review 
reported that it is possible to decrease infection rates by 10% to 70%. 5  
Efforts to reduce CAUTI have been focused to adults, with positive results found in 2013 
and 2014 by the US national healthcare safety network (NHSN), compared with previous years, 
but much less is known on the global burden of CAUTI in paediatric and neonatal populations.1,6 
Efficacy of interventions to prevent CAUTI are usually derived from adult guidelines and specific 
recommendations may not be applicable to neonates and  children.7-9 Interventions that have been 
shown to be effective in adults may require adaptation for use in the paediatric/neonatal 
population. 
 Recently, and built on the findings of the European Centre for Disease Prevention and 
Control (ECDC) key components 10 the World Health Organization (WHO) described eight core 
components for effective infection prevention and control programmes, among which figured the 
adoption of multimodal strategy HAI prevention. 11 A multimodal strategy consists of several 
elements or components (three to five) implemented in an integrated manner, that includes tools 
as bundles and checklists, developed by multidisciplinary teams that take into account local 
conditions.11 By consensus, components of the multimodal strategy must be simultaneously 
applied to achieve sustained behaviour change and HAI reduction. 11 
Reported CAUTI prevention interventions include: hand hygiene before urinary catheter 
insertion, use of an aseptic technique and sterile supplies for catheter insertion, hand hygiene 
before and after manipulation of catheter or bag and daily evaluation for medical necessity with 
prompt removal of catheters when no longer indicated. 7,12  
Considering these aspects, the aim of this systematic review was to identify all studies that 
evaluated the efficacy of an intervention for CAUTI prevention in hospitalized children and 
neonates.  
 
Material and Methods: 
A systematic literature search was conducted using PubMed, Cochrane Database of Systematic 
Reviews, LILACS (Literatura Latino Americana em Ciências da Saúde), SCIELO (Scientific 
Electronic Library of Science), DOAJ (Directory of Open Access Journals) databases. Studies 
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were searched in PubMed using the following search: strategies[All Fields] AND 
("Prevent"[Journal] OR "prevent"[All Fields]) AND catheter-associated[All Fields] AND 
("urinary tract infections"[MeSH Terms] OR ("urinary"[All Fields] AND "tract"[All Fields] AND 
"infections"[All Fields]) OR "urinary tract infections"[All Fields] OR ("urinary"[All Fields] AND 
"tract"[All Fields] AND "infection"[All Fields]) OR "urinary tract infection"[All Fields]); 
catheter-associated[All Fields] AND ("urinary tract infections"[MeSH Terms] OR ("urinary"[All 
Fields] AND "tract"[All Fields] AND "infections"[All Fields]) OR "urinary tract infections"[All 
Fields] OR ("urinary"[All Fields] AND "tract"[All Fields] AND "infection"[All Fields]) OR 
"urinary tract infection"[All Fields]) AND ("prevention and control"[Subheading] OR 
("prevention"[All Fields] AND "control"[All Fields]) OR "prevention and control"[All Fields] OR 
"prevention"[All Fields]). For the other databases similar search terms were applied which 
concerned “strategies to prevent catheter-associated urinary tract infection” and “catheter-
associated urinary tract infection prevention”. Filters applied were period: from 1 January 1995 to 
31 December 2017; ages: neonates, infants, children; languages: English, French, German, Italian, 
Portuguese, and Spanish. We conducted this systematic review following the PRISMA guideline. 
13 
Eligibility criteria 
The following study designs were eligible for inclusion: controlled and non-control before-and-
after studies, (controlled) interrupted time series analyses, and randomized controlled trials, 
quantitative or qualitative studies on interventions in both adults and children were eligible if data 
on children could be extracted. Reviews, case series, letters, notes, conference abstracts, and 
opinion articles were excluded. Studies in outpatient care, primary care, long-term care were also 
excluded.  
Quality of articles and risk of bias  
Quality of articles was assessed using the integrated quality criteria for systematic review of 
multiple study designs (ICROMS) tool.14 In summary, the tool consists of two parts: the first is a 
scored list of quality criteria specific for each study design, as well as scored criteria applicable 
across all study designs; the second is a ‘decision matrix’, which determines the robustness of the 
study by identifying minimum requirements according to the study type and the relevance of the 
study to the review question. Only studies with a pre-determined minimum score and mandatory 
criteria, according the ICROMS methodology were included in the final analysis. (Annex) 
Data collection 
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Data were extracted using a standardized data-extraction form which summarized the study details 
including authors, year of publication, country or countries where the study was performed, time 
frame of the study and patient population (infant or early childhood, children, or adolescents). 
Article analysis:  
The search was conducted by three different investigators independently (ARAS, AFM and CBB) 
over a 3-month period. Disagreement about inclusion of an article was resolved by consensus. 
Final selection of publications for inclusion was concluded in 4 phases:  
a) First round: Filters. In this phase, age filters were applied using the pre-determined 
search terms in each search engine/database. 
b) Second round: Analysis of titles and abstracts. In this phase, titles and/or abstracts 
were checked against inclusion and exclusion criteria.  
c) Third round: Full text analysis. Articles were checked again against inclusion and 
exclusion criteria. For studies reporting on mixed adult/paediatric study populations, and 
settings other than acute-care hospitals, articles were excluded if paediatric data was not 
reported separately. Quality assessment. Remaining full text articles were assessed for 
quality. Only articles meeting the minimal score and the mandatory criteria were kept.   
d) Final round: Inclusion of cross-references. Articles with interventions in 
children/neonates and cited by systematic reviews or in the remaining articles from the 
previous round were also included in the final list of articles. 
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Results: 
Results of search: 
A total of 99 titles and abstracts were identified. After full text sift and quality assessment, six 
articles remained for final analysis (figure 1). 
 
Figure 1. Systematic review profile – Interventions to prevent urinary catheter-associated 
infections in children and neonates (1995-2017) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Initial search terms: Strategies to prevent 
Catheter-associated urinary tract 
infection/Prevention of catheter-associated 
urinary tract infection; filters applied. 
55 articles excluded: 32 
interventions in adults only, 15 type 
of article, 4 duplicated, 4 other 
scenario/age not reported 
42 articles excluded- Abstract and 
title not related to children or 
neonates 
99 articles - 2nd round of analysis: review of 
title and abstracts 
57 articles remaining- 3rd round: Full text 
analysis  Intervention done/hospital 
setting/children and/or neonates 
2 articles included  
4 articles included by  cross- 
referencing 
6 articles included for data extraction and analysis 
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Included studies:  
Four of the identified articles used interrupted time series analysis,15-18 one was a randomized 
controlled trial,19 and one was a non-controlled before-and-after study.20 Characteristics of the 
studies are summarized in Table 1. 
Study population setting: 
Four studies included patients admitted to paediatric intensive care units,15,18-20 two studies 
included participants from all wards of paediatric hospitals.16,17 All six studies included patients 
from single centers and all of them included only patients between 0-18 years old age.  
Types of intervention: 
Four studies used a multimodal strategy.16, 18-20 The first study analysed five components: aseptic 
rules during catheter insertion and removal, cleaning the urethral meatus with sterile water, use of 
a new silicone catheter per insertion with a closed sterile drainage system, using a sterile 
technique, and daily evaluation of catheter requirement.20 The second study applied four 
components: placement of indwelling urinary catheters only for approved indications; insertion of 
urinary catheters using an aseptic technique /insertion checklist; maintenance of urinary catheters 
based on principles of asepsis and position patient and collection device to assist in urine drainage; 
review of urinary catheter necessity daily and prompt removal when indications are no longer 
valid. 16 The third study applied a hospital-wide initiative to improve patient safety by 
implementing high-reliability practices as part of a quality improvement (QI) program aimed at 
reducing all preventable harm, including reduction of CAUTI rates .17 And the last study analysed 
four components: aseptic insertion; use of closed anti-reflux drainage systems; maintenance of the 
drainage bag under the bladder level; and closed drainage systems.18 One study analysed efficacy 
of peri-urethral cleaning in preventing CAUTIs prior to indwelling urinary catheter insertion,19 
one study described the association of the presence of a physician safety champion with urinary 
catheter device utilization ratios (DUR).15 
 
Outcome measures:  
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Statistically significant difference in CAUTI rates before and after intervention were 
reported by three studies. 16,18,19 Two studies did not find CAUTI reduction at all,15,19 and  one 
study described a non-significant trend.17 
Risk of bias in included studies: 
Details about the study quality are summarized in Table 2.  The following components 
were assessed: selection bias (sequence generation and allocation concealment), performance bias 
(blinding of groups), detection bias (blinding of outcomes), reporting bias (selective outcome 
reporting), attrition bias (incomplete data outcome) and other bias. Bias was assessed using the 
Cochrane Risk of Bias Assessment Tool. 21 
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Table 1. Strategies and interventions for CAUTI prevention in hospitalized children and neonates: systematic review 1995-2017. 
Author, year, 
Country 
Study 
design   
Setting,  Patients Age  Summary of key findings 
Düskaya 2017, 
Turkey  
RCT 
 
Single center; 
PICU 
122 1 Month to18 
years  
• No statistically significant differences of CAUTI rates in the 3 groups (p = 0.08) a  
 
Düskaya, 2016, 
Turkey  
NCBA 
 
Single 
center;PICU 
390 1 Month to18 
years 
 
• Reduction of CAUTI rates from 5.8 to 1.5 per 1000/UC-days ( p <.001)a 
• No impact in colonization or contamination after bundle implementation 
Zavalkoff, 2015, 
Canadá 
ITS 
 
Single center; 
PICU 
 
730 Age not described •Higher rates of urinary catheter DUR during the pre-intervention period versus post-
intervention period- 0.44 (95%CI 0.42–0.45) x 0.39 (95% CI 0.38–0.40) – p<0.0001) 
and RR 0.89 (95%CI 0.86-0.93) 
•Decrease of 17% in the urinary catheter DUR when the safety champion was present 
(OR 0.83; 95%CI 0.77–0.90).  
•The rate of catheter-associated urinary tract infections did not change. 
Davis 2014, 
USA 
ITS 
 
Single center; all 
wards (paediatric 
hospital)  
44 (21 pre- 
intervention, 23 
post-
intervention) 
All ages,  •Reduction of 50% in mean monthly CAUTI rate after bundle implementation 
(95%CI 21.28 to 20.12; p = 0.02) from 5.41 to 2.49 per 1000 UC-days.  
•The median monthly catheter utilization ratio remained unchanged; 
  
Brilli, 2013, USA  
 
ITS 
 
Single center; all 
wards 
 
76 pre- 
intervention,  
50 post- 
intervention 
Age not described •Decrease of hospital-wide CLABSI, CAUTI, and surgical site infection rates 
without statistical significance. Data not showed                                                     
• Decrease of observed hospital mortality decreased from 1.0% to 0.75% (P < .001). b                      
Esteban, 2013, 
Spain 
ITS 
 
Single center; 
medical and 
surgical PICU 
 
 
851 (pre- 
intervention, 
822 post-
intervention), 
940 (follow-
up) 
1 week to 18 
years  
•Significantly lower CAUTI rate in the intervention period than in the pre-
intervention period (5.8/1,000 vs 23.3/1,000 UC-days; p < 0.001) a 
•Lower HAI rates  in the intervention period than in pre-intervention period (12.5/1,000 
vs 32.8/1,000 patient-days; p < 0.001). a 
 
CAUTI= Catheter-associated urinary tract infection CI= confidence interval  CLABSI= Central-line associated bloodstream infection DUR= Device utilization ratio   
HAI=Healthcare-associated infections ITS= Interrupted time series NCBA=Non-controlled before-and-after study PICU = paediatric intensive care unit RCT= Randomized 
controlled trial.  RR= relative risk  OR= odds ratio VAP= ventilator-associated pneumonia   
a
 Chi-square (Fisher’s exact)test   b t-test 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
10 
 
Table 2- Bias of studies included 
Studies Random 
sequence 
generation 
(selection 
bias) 
Allocation 
concealment 
(selection 
bias) 
Blinding of 
participants and 
personnel 
(performance 
bias)  
Blinding of 
outcome 
assessment 
(detection 
bias) 
Incomplete 
outcome 
data 
(attrition 
bias) 
Selective 
reporting 
(reporting 
bias) 
Other 
bias 
Düskaya 
2017 
+ ++ +++ ++ + + + 
Düskaya 
2016 
+++ +++ +++ + + + + 
Zavalkoff 
2015 
+ + +++ + + + + 
Davis 
2014 
++ + +++ +++ +++ + + 
Brilli 
2013 
++ ++ ++ ++ +++ + + 
Esteban 
2013 
++ ++ +++ + +++ ++ + 
+ Low Risk     ++ Unclear risk of bias   +++ High risk of bias 
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Summary table- Positive findings of articles included in final analysis, according strategy used to reduce CAUTI in 
children. 
Author, year  Type of 
intervention 
Components Positive 
findings in 
reduction of 
CAUTI rates? 
Düskaya, 2017 Single intervention ●Peri-urethral cleansing (10% povidine-iodine solution or 
0.05% cloherexidine gluconate solution or sterile water 
No 
 
Duskaya, 2016 
 
Multimodal 
strategy  
● aseptic rules during catheter insertion and removal 
● cleaning urethral meatus with sterile water, 
●using of a new silicone catheter per insertion (with a 
closed sterile drainage system using a sterile technique. 
● evaluation of catheter requirement daily. 
 
Yes 
Zavalkoff, 2015 Adoption of 
physician safety 
champion (PSC) 
● Regular reports of CAUTI rates by PSC 
● Possibility of  UC removal daily 
● Quartely quality improvement follow-up rounds and 
feedback to PICU team 
No 
 
 
Davis 2014  
 
 
Multimodal 
strategy  
●Insertion of UC only with  approved indication;  
● aseptic technique for insertion 
● insertion check-list 
●maintenance of UC based on asepsis principles 
●daily review of  UC necessity and prompt removal when 
indications are no  
Yes 
 
Brilli, 2013  
 
Multimodal 
strategy 
● Reducing urinary-catheter days 
● Standardizing insertion techniques 
●Compliance with insertion and maintenance 
Yes* 
 
Esteban, 2013  
 
Multimodal 
strategy 
● Aseptic insertion;  
● Use of closed anti-reflux drainage systems;  
● Maintenance of the drainage bag under the bladder level;  
●Closed drainage systems 
Yes 
*without statistical significance   UC=urinary –catheter  PICU= pediatric intensive care-unit CAUTI- 
catheter-associated urinary tract infection 
Discussion:  
This systematic review identified a low number of studies on the efficacy of CAUTI 
prevention programs in hospitalized children and neonates. The main successful strategy was the 
adoption of a multimodal strategy with at least four simultaneously applied components such as 
placement of indwelling urinary catheters for an approved indication only, aseptic technique 
during catheter insertion and removal, use of a new silicone catheter per insertion attempt with a 
closed sterile drainage system, daily review of urinary catheter necessity and prompt removal 
when indications are no longer present, cleaning the urethral meatus with sterile water and 
maintenance of the drainage bag below bladder level. 
Several guidelines on HAI prevention are available, including infections related to urinary 
catheter use. 7,8,22 The evidence supporting most of these recommendations has been generated in 
adult populations where urinary catheterization use is more frequent than in children/neonates. 
Our review showed that the components used as part of a multimodal strategy for CAUTI 
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prevention in children are also found in most of adult guidelines.7,8 Although multimodal 
strategies a whole were effective in CAUTI prevention, it is not possible to determine, which of 
the components/elements had the greatest effect on CAUTI reduction.   
In the absence of evidence, there were concerns to support the application of adult CAUTI 
prevention guidelines in children and neonates. However, some studies have evaluated 
components just in adult population as: use of smallest gauge catheters; evaluation of alternative 
methods for measuring urine volume; avoidance of catheter irrigation to prevent of patients and 
family; use of antibiotic-impregnated urinary catheters; role of education programmes; choice of 
catheter type and documentation of catheter insertion. 7-9 The applicability of these components 
and role of these components for children and neonates is undefined, until the present moment.  
Despite existence of well-accepted guidance on CAUTI prevention for adults, the exact 
disease burden and best methods for CAUTI prevention in hospitalised children and neonates is 
not well defined.7 Previous studies about international infection prevention and control (IPC) 
guidelines have demonstrated gaps in specific recommendations for interventions necessary to 
prevent CAUTI and surgical site infection in children. 23  
In this study, despite finding many publications on CAUTI prevention, we identified only 
six papers with specific interventions to reduce CAUTI in the paediatric population. In just 4 of 6 
studies, reduction of CAUTI rates was achieved. Interestingly, all 3 studies that reported 
significant CAUTI reduction applied a multimodal prevention strategy.  Another interesting 
finding is that all studies included came from single-center hospitals which may limit the 
generalisability of these findings.    
The multimodal strategy using simultaneous application of prevention components is used 
for HAI prevention including bloodstream infection, ventilator-associated pneumonia, catheter-
associated urinary tract infection, surgical site infection among others. For example, Payne and 
colleagues, in a recent systematic review of the role of multimodal strategy in reducing central 
line-associated bloodstream infections in the neonatal unit (NNU), concluded that this strategy 
may reduce CLABSI rates in the NNU, though it is not clear, which bundle elements are effective 
in specific settings. 24  
Simultaneous interventions, used as a multimodal strategy to reduce CAUTI rates are well 
described in adult populations. In a multi-center study involving 13 adult ICUs in 10 Turkish 
cities, a 47% decrease in CAUTI rates was observed after implementation of a multi-dimensional 
infection control approach.25 The importance of this strategy was also demonstrated in another 
multi-center study in 15 countries, using a multi-dimensional approach with 6 components: (1) 
bundle of infection control interventions, (2) education, (3) outcome surveillance, (4) process 
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surveillance, (5) feedback of CAUTI rates, and (6) performance feedback of infection control 
practices. In this setting, the intervention achieved a 37% reduction in CAUTI rates (from 7.86 per 
1,000 UC-days, to 4.95 per 1,000 UC-days [relative risk (RR) 0.63 (95 % confidence interval [CI] 
0.55–0.72)]). 26 
Although our systematic review was conducted using the PRISMA statement 13, the study 
has some limitations. First, it is possible that some articles or reports may have been missed. This 
problem was minimized by cross-referencing in identified studies, reviews, and meta-analyses. 
Second, quality may be a concern, limiting the evidence of the findings. However, applying the 
rigorous ICROMS methodology selected for studies of sufficient quality. 
 
Conclusion:  
We found evidence to support the use of a multimodal strategy for CAUTI prevention in 
hospitalised children and neonates. Multimodal strategies for CAUTI prevention should be 
adopted as standard of care for paediatric healthcare facilities, and include at least four different 
components, applied simultaneously. We can suggest that future CAUTI prevention studies should 
apply a multimodal strategy, and should be organised in multiple centers. The following strategies, 
which form part of adult CAUTI prevention guidelines, should be assessed in future 
paediatric/neonatal CAUTI prevention research: practical education programmes, choice of 
catheter type, evaluation of alternative methods to urinary catheters, documentation of catheter 
insertion, catheter size, cleaning of the urethral meatus, use of antibiotic-impregnated urinary 
catheters and catheter irrigation.  
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Annex  - Quality criteria for application per study design- Integrated quality criteria for review of multiple study designs 
(ICROMS) 
Quality criteria Study design b 
Dimension Specific criteria a RCT CBA CITS NCITS NCBA CS QUAL 
1. Clear aims and justification a. Clear statement of the aims of research? 
b. Rationale for number of pre-and post-intervention points 
or adequate baseline measurement 
c. Explanation for lack of control group 
d. Appropriateness of qualitative methodology 
e. Appropriate study design 
++ 
x 
 
x 
x 
x 
++ 
x 
 
x 
x 
x 
++ 
+ 
 
x 
x 
x 
++ 
++ 
 
+ 
x 
x 
++ 
++ 
 
+ 
x 
x 
++ 
x 
 
x 
x 
x 
++ 
x 
 
x 
+ 
++ 
2. Managing bias in sampling 
or between groups 
a. Sequence generation 
b. Allocation concealment 
c. Justification for sample choice 
d. Intervention and control group selection designed to 
protect against systematic difference/selection bias 
e. Comparability of groups 
f. Sampling and recruitment 
++ 
++ 
x 
x 
 
x 
x 
x 
x 
x 
++ 
 
x 
x 
x 
x 
x 
x 
 
x 
x 
x 
x 
++ 
x 
 
x 
x 
x 
x 
++ 
x 
 
x 
x 
x 
x 
x 
x 
 
++ 
x 
x 
x 
x 
x 
 
x 
++ 
3. Managing bias in outcome 
measurements and blinding 
a. Blinding 
b. Baseline measurement- protection against selection bias 
c. Protection against contamination 
d. Protection against secular changes 
e. Protection against detection bias: blinded assessment of 
primary outcome measures 
f. Reliable primary outcome measures 
g. Comparability of outcomes 
++ 
x 
x 
x 
+ 
 
+ 
x 
x 
++ 
++ 
x 
+ 
 
+ 
x 
x 
x 
x 
++ 
+ 
 
+ 
x 
x 
x 
x 
x 
+ 
 
+ 
x 
x 
x 
x 
x 
+ 
 
+ 
x 
x 
x 
x 
x 
+ 
 
+ 
++ 
x 
x 
x 
x 
x 
 
+ 
x 
4. Managing bias in follow-up a. Follow-up of subjects (protection against exclusion bias) 
b. Follow-up of patients of episodes of care 
c. Incomplete outcome data addressed 
+ 
+ 
+ 
x 
x 
+ 
x 
x 
+ 
x 
x 
+ 
x 
x 
+ 
x 
x 
++ 
x 
x 
+ 
5. Managing bias in other 
study aspects 
a. Protection against detection bias: intervention unlikely to 
affect data collection 
b. Protection against information bias 
c. Data collection appropriate to address research aims 
d. Attempts to mitigate effects of no control 
+ 
x 
x 
x 
+ 
x 
x 
x 
+ 
x 
x 
x 
+ 
x 
x 
++ 
+ 
x 
x 
++ 
x 
+ 
x 
x 
x 
x 
+ 
x 
6. Analytical rigour a. Sufficient data points to enable reliable statistical 
inference 
b. Shaping of intervention effect specified 
c. Analysis sufficiently rigorous/free from bias 
x 
x 
+ 
x 
x 
+ 
++ 
+ 
+ 
x 
x 
+ 
x 
x 
+ 
x 
x 
+ 
x 
x 
+ 
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7. Managing bias in 
reporting/ethical 
considerations 
a. Free of selective outcome reporting 
b. Limitations addressed 
c. Conclusions clear and justified 
d. Free of other bias 
e. Ethics issues addressed 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
a Applicability of quality criteria to each study design: + Criteria to be included in quality assessment for study design; ++ Mandatory criteria to be met quality 
assessment; x Criteria not to be applied in quality assessment for study design.  
b
 Study designs: RCT =randomised controlled trial; CBA =controlled before-after; CITS = controlled interrupted time series; CS = cohort study; NCITS =non-
controlled interrupted time series; NCBA =non-controlled before-after; QUAL = qualitative.
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Annex -Decision matrix e mandatory criteria and minimum score for study type to be included in 
review.  
Study Design a Mandatory criteria b Minimum score 
RCT, cRCT 1A, 2A, 2B, and 3A 22 
CBA 1A, 2D, 3B and 3C 18 
CITS 1A, 3D and 6A 18 
NCITS 1A, 1B, 2C and 5D 22 
NCBA 1A, 1B, 2C and 5D 22 
Cohort  1A, 2E, 3G and 4C 18 
Qualitative 1A, 1E and 2F 16 
 
a
 Study Designs: RCT = randomised controlled trial; CBA =controlled before-after; CITS = 
controlled interrupted time series; cRCT =cluster-randomized controlled trial; NCITS = 
noncontrolled interrupted time series; NCBA =non-controlled before-after. 
 
b
 Scores applicable to each criteria: Yes (criterion met) =2 points; Unclear (unclear whether or not 
the criterion is met) =1 point; No (criterion not met) = 0 points. 
 
Adapted from Zingg W et al. Innovative tools for quality assessment: integrated quality criteria for 
review of multiple study designs (ICROMS). Public Health 2016;133:19-37. 
 
 
 
 
 
 
 
